歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01672 歌礼制药-B

未开盘 07-28 16:09:12

11.240

+0.520

+4.85%

最高11.300	最低10.480	成交量240.00万
今开10.960	昨收10.720	日振幅7.65%
总市值108.35亿	流通市值108.35亿	总股本9.64亿
成交额2,620万	换手率0.25%	流通股本9.64亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01672","market":"HK","secType":"STK","nameCN":"歌礼制药-B","latestPrice":11.24,"timestamp":1753690152005,"preClose":10.72,"halted":0,"volume":2400000,"delay":0,"floatShares":964000000,"shares":964000000,"eps":-0.3283933200615442,"marketStatus":"未开盘","change":0.52,"latestTime":"07-28 16:09:12","open":10.96,"high":11.3,"low":10.48,"amount":26200440,"amplitude":0.076493,"askPrice":11.24,"askSize":7000,"bidPrice":11.18,"bidSize":31000,"shortable":3,"etf":0,"ttmEps":-0.3283933200615442,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753752600000},"marketStatusCode":0,"adr":0,"listingDate":1533052800000,"exchange":"SEHK","adjPreClose":10.72,"openAndCloseTimeList":[[1753666200000,1753675200000],[1753678800000,1753689600000]],"volumeRatio":0.42162,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01672","defaultTab":"news","newsList":[{"id":"2554092725","title":"歌礼制药-B盘中异动 下午盘股价大涨5.04%报11.260港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554092725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554092725?lang=zh_cn&edition=full","pubTime":"2025-07-28 15:16","pubTimestamp":1753687009,"startTime":"0","endTime":"0","summary":"2025年07月28日下午盘15时16分，歌礼制药-B股票出现异动，股价快速上涨5.04%。截至发稿，该股报11.260港元/股，成交量181.6万股，换手率0.19%，振幅7.28%。资金方面，该股资金流入1063.67万港元，流出768.908万港元。歌礼制药-B股票所在的生物技术行业中，整体涨幅为2.62%。其相关个股中，北海康成-B、复宏汉霖、方达控股涨幅较大，振幅较大的相关个股有北海康成-B、方达控股、创胜集团-B，振幅分别为20.51%、18.18%、14.95%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728151649a6c568f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728151649a6c568f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1515","BK1161","BK1191","BK1574","01477"],"gpt_icon":0},{"id":"2554698749","title":"歌礼制药-B(01672)：小分子GLP-1R激动剂ASC30每月一次皮下储库型制剂的美国12周IIa期研究完成首批肥胖或超重受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2554698749","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554698749?lang=zh_cn&edition=full","pubTime":"2025-07-28 08:17","pubTimestamp":1753661877,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 发布公告，小分子GLP-1受体激动剂 ASC30每月一次皮下储库型制剂治疗肥胖症的美国12周IIa期研究已完成首批受试者给药，受试者为肥胖人群或伴有至少一种体重相关合并症的超重人群。预计将于2026年第一季度获得顶线数据。ASC30是一款正在临床研究中的小分子GLP-1R偏向激动剂，具有独特和差异化性质，使得同一小分子同时适用于口服片剂和皮下注射给药成为可能。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1515","BK4144","GLP","BK1161","01477","BK1191","BK4590","01672"],"gpt_icon":0},{"id":"2553027521","title":"港股康希诺拉升涨近14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553027521","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553027521?lang=zh_cn&edition=full","pubTime":"2025-07-24 13:32","pubTimestamp":1753335135,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1794554557.SGD","07226","BK4614","BK1574","IE00BPRC5H50.USD","LU2488822045.USD","BK1161","HSCEI","01672","LU0348784397.USD","688185","159837","09926","BK1515","LU0348783233.USD","HSTECH","LU1720050803.USD","LU0417516571.SGD","01477","BK0239","YANG","BK1191","IE00B543WZ88.USD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2553202493","title":"歌礼制药-B大涨5.32% 近日完成ASC47与司美格鲁肽联合使用的28例肥胖受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2553202493","media":"港美通","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553202493?lang=zh_cn&edition=full","pubTime":"2025-07-24 13:21","pubTimestamp":1753334484,"startTime":"0","endTime":"0","summary":"7月24日13:14，歌礼制药-B(01672)上涨5.32%，该股报11.080港元，最高报11.080港元，最低报10.380港元，成交量181.49万股，成交额1931.00万港元。消息面上，歌礼制药-B近日发布公告，宣布其在美国开展的联合用药研究已完成所有28例肥胖受试者的给药。这项研究旨在评估超长效皮下注射小分子THRβ激动剂ASC47单次给药与司美格鲁肽联合使用的安全性、耐受性以及初步疗效。该临床试验于2025年5月开始入组，所有受试者在两个月内快速完成入组。预期将在2025年第四季度获得顶线数据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072418392994b816ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072418392994b816ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1515","BK1574","BK1191","01477","BK1161"],"gpt_icon":0},{"id":"2553234029","title":"歌礼制药-B07月22日主力净流出223.2万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2553234029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553234029?lang=zh_cn&edition=full","pubTime":"2025-07-22 16:16","pubTimestamp":1753172165,"startTime":"0","endTime":"0","summary":"07月22日, 歌礼制药-B股价跌2.74%，报收11.38元，成交金额6528.6万元，换手率0.58%，振幅6.15%，量比0.74。歌礼制药-B今日主力资金净流出223.2万元，上一交易日主力净流入294.1万元。该股近5个交易日上涨22.16%，主力资金累计净流入3532.4万元；近20日主力资金累计净流入2754.8万元，其中净流入天数为12日。该股主力净额占比0.02%，港股市场排名2395/2671。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722170950a45beb7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722170950a45beb7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","01672","BK1574","BK1161","01477"],"gpt_icon":0},{"id":"2553471362","title":"歌礼制药-B8月15日举行董事会会议考虑及批准中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2553471362","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553471362?lang=zh_cn&edition=full","pubTime":"2025-07-21 16:41","pubTimestamp":1753087310,"startTime":"0","endTime":"0","summary":"格隆汇7月21日丨歌礼制药-B(01672.HK)宣布，董事会会议将于2025年8月15日(星期五)举行，藉以(其中包括)考虑及批准公司及其附属公司截至2025年6月30日止六个月的中期业绩及其发布，并考虑建议派发中期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072116422097ae6ad4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072116422097ae6ad4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","01477","01672","BK1515","BK1191"],"gpt_icon":0},{"id":"1169762816","title":"一周港股牛熊榜 | 医药股乐普生物周飙62%、歌礼涨31%；金融科技杀入Web3.0，云锋暴涨46%；芯片短缺缓解、金山云涨35%","url":"https://stock-news.laohu8.com/highlight/detail?id=1169762816","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169762816?lang=zh_cn&edition=full","pubTime":"2025-07-18 18:15","pubTimestamp":1752833756,"startTime":"0","endTime":"0","summary":"中邮证券表示，中国在全球创新药BD交易中的项目数占比从2019年的3%跃升至2024年的13%，金额占比从1%提升至28%。此外，润建股份与云知声正式达成战略合作协议。28例受试者入组于两个月内快速完成。此配售价较最后交易日收市价及前五个交易日平均收市价分别折让约17.04%及17.44%。值得注意的是，7月13日，九方智投控股发布公告，公司预计上半年股东应占净溢利介乎约8.3亿元至8.7亿元，较去年同期的净亏损1.74亿元实现扭亏为盈。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09636","00917","HSI","06683","01672","HSTECH","HSCEI","00376","03896","02145","01364","02157","09678"],"gpt_icon":1},{"id":"2552457172","title":"歌礼制药午后强势走强，ASC47临床前研究表明具备减脂增肌降体重潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2552457172","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552457172?lang=zh_cn&edition=full","pubTime":"2025-07-18 14:42","pubTimestamp":1752820928,"startTime":"0","endTime":"0","summary":"中信建投指出，ASC47临床前研究具备减脂增肌降体重效果，潜力十足。公司的ASC47临床前研究表明，在联合司美格鲁肽给药小鼠时，相较于司美格鲁肽组，联合组展示了更高的体重下降趋势。整体看，ASC47在临床前的动物模型中展现出了初步的减脂增肌和降体重能力，后续人体研究结果可期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071814422997aac3e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071814422997aac3e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","BK1191","BK1574","01672","01477"],"gpt_icon":0},{"id":"1126230432","title":"港股生物医药股午后持续拉升，乐普生物-B涨超17%","url":"https://stock-news.laohu8.com/highlight/detail?id=1126230432","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126230432?lang=zh_cn&edition=full","pubTime":"2025-07-18 14:10","pubTimestamp":1752819025,"startTime":"0","endTime":"0","summary":"7月18日，港股生物医药股午后持续拉升，$乐普生物-B(02157)$涨超17%，$歌礼制药-B(01672)$涨超16%，$加科思-B(01167)$涨近14%，$荃信生物-B(02509)$涨超8%，$荣昌生物(09995)$涨超6%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995","01672","02157"],"gpt_icon":0},{"id":"1122103043","title":"港股生物医药股延续强势，恒瑞医药涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1122103043","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122103043?lang=zh_cn&edition=full","pubTime":"2025-07-18 10:15","pubTimestamp":1752804908,"startTime":"0","endTime":"0","summary":"7月18日，港股生物医药股延续强势，$歌礼制药-B(01672)$涨超7%，$恒瑞医药(01276)$涨超6%，$荣昌生物(09995)$涨超5%，$亚盛医药-B(06855)$、$翰森制药(03692)$涨超4%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276","01672","09995"],"gpt_icon":0},{"id":"2552174524","title":"港股异动 | 歌礼制药-B(01672)早盘涨超11% ASC47联合司美格鲁肽治疗肥胖症的美国临床研究完成受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2552174524","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552174524?lang=zh_cn&edition=full","pubTime":"2025-07-17 09:36","pubTimestamp":1752716162,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，歌礼制药-B早盘涨超11%，截至发稿，涨11.6%，报10.2港元，成交额2046.21万港元。消息面上，歌礼制药发布公告，宣布其在美国开展的联合用药研究已完成所有28例肥胖受试者的给药。这项研究旨在评估超长效皮下注射小分子THRβ激动剂ASC47单次给药与司美格鲁肽联合使用的安全性、耐受性以及初步疗效。中信建投此前表示，歌礼制药的ASC30和ASC47两款药物亮相ADA大会，产品后续前景值得关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1318790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01477","BK1515","BK1574","01672","BK1161"],"gpt_icon":0},{"id":"2552224891","title":"每日卖空追踪 | 歌礼制药-B 07月16日卖空量成交6.1万股，卖空比例为2.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552224891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552224891?lang=zh_cn&edition=full","pubTime":"2025-07-16 16:30","pubTimestamp":1752654626,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间07月16日，跌1.19%，卖空量成交6.1万股%，较上一交易日减少64.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716172425a44e6106&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716172425a44e6106&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","01477","BK1191","01672","BK1515"],"gpt_icon":0},{"id":"2552122399","title":"歌礼制药-B07月16日主力净流出87.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2552122399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552122399?lang=zh_cn&edition=full","pubTime":"2025-07-16 16:16","pubTimestamp":1752653762,"startTime":"0","endTime":"0","summary":"07月16日, 歌礼制药-B股价跌1.19%，报收9.14元，成交金额2134.8万元，换手率0.24%，振幅4.54%，量比0.48。歌礼制药-B今日主力资金净流出87.6万元，上一交易日主力净流入268.6万元。该股近5个交易日上涨2.81%，主力资金累计净流出57.1万元；近20日主力资金累计净流出613.7万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716171153a6ad17c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716171153a6ad17c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1515","BK1161","01672","BK1191","01477"],"gpt_icon":0},{"id":"2551392601","title":"智通港股早知道 | 央行将开展14000亿元买断式逆回购操作 中金公司(03908)发盈喜","url":"https://stock-news.laohu8.com/highlight/detail?id=2551392601","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551392601?lang=zh_cn&edition=full","pubTime":"2025-07-15 07:17","pubTimestamp":1752535022,"startTime":"0","endTime":"0","summary":"7月15日，中国人民银行将以固定数量、利率招标、多重价位中标方式开展14000亿元买断式逆回购操作，其中3个月(91天)期限为8000亿元、6个月期限为6000亿元。配售价为每股54.30至55港元，较前收盘价折让8.3%至9.5%。预计归属于上市公司股东的扣除非经常性损益的净利润为人民币31.60亿元到人民币35.10亿元，与上年同期相比增加人民币11.41亿元到人民币14.91亿元，同比增长57%到74%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1317697.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01672","BK1501","BK1147","BK1564","BK1516","03958","SG9999002828.SGD","HSTECH","BK4614","HSCEI","BK1191","LU2460026573.USD","BK1515","YANG","601995","BK1161","BK0276","02005","BK1574","03908"],"gpt_icon":1},{"id":"2551139605","title":"歌礼制药-B(01672)：歌礼脂肪靶向、每月一次注射的小分子THRβ激动剂ASC47 联合司美格鲁肽治疗肥胖症的美国临床研究完成所有受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2551139605","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551139605?lang=zh_cn&edition=full","pubTime":"2025-07-15 06:58","pubTimestamp":1752533899,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 发布公告，评估超长效皮下注射ASC47单次给药联合司美格鲁肽在不伴有2型糖尿病的肥胖受试者中的安全性、耐受性以及在第29天的初步疗效的随机、双盲、安慰剂对照研究已于近期完成所有28例受试者给药。在头对头比较的DIO小鼠模型中，低剂量ASC47与司美格鲁肽联合用药比司美格鲁肽单药疗法多减重56.7%，且不减肌。预计将于2025年第四季度获得ASC47和司美格鲁肽联合用药研究的顶线数据。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1317695.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01477","BK1574","THR","BK1515","BK4096","BK1161","01672","BK1191"],"gpt_icon":0},{"id":"2551183734","title":"歌礼制药-B07月14日遭主力抛售58.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551183734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551183734?lang=zh_cn&edition=full","pubTime":"2025-07-14 16:15","pubTimestamp":1752480951,"startTime":"0","endTime":"0","summary":"07月14日, 歌礼制药-B股价跌0.11%，报收8.85元，成交金额3111.2万元，换手率0.37%，振幅5.42%，量比0.69。歌礼制药-B今日主力资金净流出58.9万元，上一交易日主力净流出413.9万元。该股近5个交易日下跌4.32%，主力资金累计净流出493.3万元；近20日主力资金累计净流入297.5万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714170741a6a857c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714170741a6a857c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","BK1161","01672","BK1515","01477"],"gpt_icon":0},{"id":"2550939490","title":"每日卖空追踪 | 歌礼制药-B 07月11日卖空量成交8万股，卖空比例为0.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550939490","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550939490?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:30","pubTimestamp":1752222624,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间07月11日，跌1.77%，卖空量成交8万股%，较上一交易日减少77.46%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711172328a6a37d14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711172328a6a37d14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","01672","BK1161","BK1515","01477"],"gpt_icon":0},{"id":"2550001686","title":"歌礼制药-B盘中异动 下午盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550001686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550001686?lang=zh_cn&edition=full","pubTime":"2025-07-11 13:08","pubTimestamp":1752210484,"startTime":"0","endTime":"0","summary":"2025年07月11日下午盘13时08分，歌礼制药-B股票出现波动，股价快速跳水5.10%。截至发稿，该股报8.560港元/股，成交量584.1万股，换手率0.61%，振幅9.87%。歌礼制药-B股票所在的生物技术行业中，整体涨幅为2.39%。其相关个股中，药明康德、诺诚健华、药明合联涨幅较大，振幅较大的相关个股有华昊中天医药-B、正大企业国际、宜明昂科-B，振幅分别为14.21%、13.54%、13.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711130804a443f85d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711130804a443f85d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01477","BK1515","BK1574","01672","BK1161"],"gpt_icon":0},{"id":"2550381996","title":"每日卖空追踪 | 歌礼制药-B 07月09日卖空量成交8.6万股，卖空比例为2.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550381996","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550381996?lang=zh_cn&edition=full","pubTime":"2025-07-09 16:30","pubTimestamp":1752049824,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间07月09日，涨1.95%，卖空量成交8.6万股%，较上一交易日减少85.2%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172225a69f188f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172225a69f188f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","01477","BK1574","BK1161","01672"],"gpt_icon":0},{"id":"2550801666","title":"歌礼制药-B07月09日主力净流入72.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2550801666","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550801666?lang=zh_cn&edition=full","pubTime":"2025-07-09 16:16","pubTimestamp":1752048960,"startTime":"0","endTime":"0","summary":"07月09日, 歌礼制药-B股价涨1.95%，报收8.89元，成交金额2795.0万元，换手率0.33%，振幅5.05%，量比0.78。歌礼制药-B今日主力资金净流入72.8万元，上一交易日主力净流出328.0万元。该股近5个交易日上涨1.83%，主力资金累计净流入101.7万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2044.8万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709170718a69f0e19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709170718a69f0e19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","01672","BK1161","BK1515","01477"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascletis.com","stockEarnings":[{"period":"1week","weight":-0.0393},{"period":"1month","weight":0.3055},{"period":"3month","weight":0.6826},{"period":"6month","weight":1.7753},{"period":"1year","weight":8.4454},{"period":"ytd","weight":2.7342}],"compareEarnings":[{"period":"1week","weight":0.0227},{"period":"1month","weight":0.0526},{"period":"3month","weight":0.1615},{"period":"6month","weight":0.2639},{"period":"1year","weight":0.5018},{"period":"ytd","weight":0.2743}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"歌礼制药有限公司是一家主要从事医药产品研发、生产和销售的投资控股公司。该公司专注于病毒性疾病、非酒精性脂肪性肝炎（NASH）或原发性胆汁性胆管炎（PBC）及肿瘤领域。该公司的产品管线包括用于慢性乙肝功能性治愈的ASC22、用于呼吸道合胞病毒（RSV）的ASC10、用于人类免疫缺陷病毒（HIV）功能性治愈的ASC22、用於新冠肺炎的ASC10及ASC11、用於NASH的ASC41、用於PBC的ASC42、用于实体瘤的ASC61、用于中、重度痤疮的ASC40等。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.137639},{"month":2,"riseRate":0.714286,"avgChangeRate":0.094063},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.058802},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.059274},{"month":5,"riseRate":0.428571,"avgChangeRate":0.007612},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.024499},{"month":7,"riseRate":0.571429,"avgChangeRate":0.040361},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.090298},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.044648},{"month":10,"riseRate":0.571429,"avgChangeRate":-0.021896},{"month":11,"riseRate":0.857143,"avgChangeRate":0.138187},{"month":12,"riseRate":0.571429,"avgChangeRate":0.13144}],"exchange":"SEHK","name":"歌礼制药-B","nameEN":"ASCLETIS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"歌礼制药-B,01672,歌礼制药-B股票,歌礼制药-B股票老虎,歌礼制药-B股票老虎国际,歌礼制药-B行情,歌礼制药-B股票行情,歌礼制药-B股价,歌礼制药-B股市,歌礼制药-B股票价格,歌礼制药-B股票交易,歌礼制药-B股票购买,歌礼制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}